Portal Vein Portal Hypertension Hepatic Vein Esophageal Varix Focal Nodular Hyperplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Couinaud C. Controlled hepatectomies and exposure of the intrahepatic bile ducts: anatomical and technical study. Paris, France: self-published; 1981.Google Scholar
  2. 2.
    Iwatsuki S, Stieber AC, Marsh JW, et al. Liver transplantation for fulminant hepatic failure. Transplant Proc 1989;21(1 Pt 2):2431–2434.PubMedGoogle Scholar
  3. 3.
    Matloff DS. Treatment of acute variceal bleeding. Gastroenterol Clin North Am 1992;21:103–118.PubMedGoogle Scholar
  4. 4.
    D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332–354.CrossRefPubMedGoogle Scholar
  5. 5.
    Hwang SJ, Lin HC, Chang CF, et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992;16:320–325.CrossRefPubMedGoogle Scholar
  6. 6.
    Panes J, Teres J, Bosch J, et al. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988;33:454–459.CrossRefPubMedGoogle Scholar
  7. 7.
    Crecelius SA, Soulen MC. Transjugular intrahepatic portosystemic shunts for portal hypertension. Gastroenterol Clin North Am 1995;24:201–219.PubMedGoogle Scholar
  8. 8.
    Fillmore DJ, Miller FJ, Fox LF, et al. Transjugular intrahepatic portosystemic shunt: midterm clinical and angiographic followup. J Vasc Interv Radiol 1996;7:255–261.PubMedCrossRefGoogle Scholar
  9. 9.
    Orloff MJ, Orloff MS, Orloff SL, et al. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 1995;180:257–272.PubMedGoogle Scholar
  10. 10.
    Henderson JM, Barnes DS, Geisinger MA. Portal hypertension. Curr Probl Surg 1998;35:379–452.PubMedGoogle Scholar
  11. 11.
    Stiegmann GV, Goff JS, Michaletz-Onody PA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527–1532.PubMedCrossRefGoogle Scholar
  12. 12.
    Langer B, Taylor BR, Mackenzie DR, et al. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology 1985;88:424–429.PubMedGoogle Scholar
  13. 13.
    Rikkers LF, Sorrell WT, Jin G. Which portosystemic shunt is best? Gastroenterol Clin North Am 1992;21:179–196.PubMedGoogle Scholar
  14. 14.
    Stanley MM, Ochi S, Lee KK, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. N Engl J Med 1989;321:1632–1638.PubMedCrossRefGoogle Scholar
  15. 15.
    Lai EC, Fan ST, Lo CM, et al. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995;221:291–298.PubMedGoogle Scholar
  16. 16.
    Simonetti RG, Liberati A, Angiolini C, et al. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 1997;8:117–136.CrossRefPubMedGoogle Scholar
  17. 17.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.CrossRefPubMedGoogle Scholar
  18. 18.
    Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Surg 1997;173:358–365.CrossRefPubMedGoogle Scholar
  19. 19.
    Reynolds M, Douglass EC, Finegold M, et al. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992;27:1080–1084.PubMedCrossRefGoogle Scholar
  20. 20.
    Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience. World J Surg 1998;22:268–277.CrossRefPubMedGoogle Scholar

Selected Readings Anatomy

  1. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 1982;6:3–9.CrossRefPubMedGoogle Scholar
  2. Couinaud C. Surgical anatomy of the liver. Several new aspects. Chirurgie 1986;112:337–342.PubMedGoogle Scholar


  1. Dixon JL, Ginsberg HN. Hepatic synthesis of lipoproteins and apolipoproteins. Semin Liver Dis 1992;12:364–372.PubMedCrossRefGoogle Scholar
  2. Mammen EF. Coagulation defects in liver disease. Med Clin North Am 1994;78:545–554.PubMedGoogle Scholar
  3. Meier PJ. Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol 1995;269(6 Pt 1):G801–G812.PubMedGoogle Scholar
  4. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991;14:551–566.CrossRefPubMedGoogle Scholar
  5. Pilkis SJ, Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 1992;54:885–909.CrossRefPubMedGoogle Scholar
  6. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology 1988;8:385–401.PubMedGoogle Scholar
  7. Steer CJ. Liver regeneration. FASEB J 1995;9:1396–1400.PubMedGoogle Scholar

Portal Hypertension

  1. Collins JC, Rypins EB, Sarfeh IJ. Narrow-diameter portacaval shunts for management of variceal bleeding. World J Surg 1994;18:211–215.CrossRefPubMedGoogle Scholar
  2. Klein AS, Sitzmann JV, Coleman J, et al. Current management of the Budd-Chiari syndrome. Ann Surg 1990;212:144–149.PubMedGoogle Scholar
  3. Langer B, Taylor BR, Mackenzie DR, et al. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology 1985;88:424–429.PubMedGoogle Scholar
  4. Millikan WJ Jr, Warren WD, Henderson JM, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg 1985;201:712–722.PubMedGoogle Scholar
  5. Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002;123:1013–1019.CrossRefPubMedGoogle Scholar
  6. Resnick RH, Chalmers TC, Ishihara AM, et al. A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med 1969;70:675–688.PubMedGoogle Scholar
  7. Rikkers LF, Jin G. Emergency shunt. Role in the present management of variceal bleeding. Arch Surg 1995;130:472–477.PubMedGoogle Scholar
  8. Stanley MM, Ochi S, Lee KK, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. N Engl J Med 1989;321:1632–1638.PubMedCrossRefGoogle Scholar
  9. Terblanche J, Kahn D, Bornman PC. Long-term injection sclerotherapy treatment for esophageal varices. A 10-year prospective evaluation. Ann Surg 1989;210:725–731.PubMedGoogle Scholar

Liver Abscess

  1. Donovan AJ, Yellin AE, Ralls PW. Hepatic abscess. World J Surg 1991;15:162–169.CrossRefPubMedGoogle Scholar
  2. Huang CJ, Pitt HA, Lipsett PA, et al. Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg 1996;223:600–609.CrossRefPubMedGoogle Scholar

Echinococcus (Hydatid) Cyst

  1. Khuroo MS, Wani NA, Javid G, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 1997;337:881–887.CrossRefPubMedGoogle Scholar
  2. Lewall DB. Hydatid disease: biology, pathology, imaging and classification. Clin Radiol 1998;53:863–874.PubMedGoogle Scholar
  3. Xynos E, Pechlivanides G, Tzortzinis A, et al. Hydatid disease of the liver. Diagnosis and surgical treatment. HPB Surg 1991;4:59–67.PubMedGoogle Scholar

Benign Neoplasms of the Liver

  1. Belli L, De Carlis L, Beati C, et al. Surgical treatment of symptomatic giant hemangiomas of the liver. Surg Gynecol Obstet 1992;174:474–478.PubMedGoogle Scholar
  2. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975;59:995–1013.PubMedGoogle Scholar
  3. Lise M, Feltrin G, Da Pian PP, et al. Giant cavernous hemangiomas: diagnosis and surgical strategies. World J Surg 1992;16:516–520.CrossRefPubMedGoogle Scholar
  4. Ros PR, Li KC. Benign liver tumors. Curr Probl Diagn Radiol 1989;18:125–155.CrossRefPubMedGoogle Scholar
  5. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991;173:426–431.PubMedGoogle Scholar

Hepatocellular Carcinoma and Cholangiocarcinoma

  1. DeMatteo RP, Fong Y, Blumgart LH. Surgical treatment of malignant liver tumours. Baillieres Best Pract Res Clin Gastroenterol 1999;13:557–574.CrossRefPubMedGoogle Scholar
  2. Dmitrewski J, El-Gazzaz G, McMaster P. Hepatocellular cancer: resection or transplantation. J Hepatobiliary Pancreat Surg 1998;5:18–23.CrossRefPubMedGoogle Scholar
  3. Gores GJ. Early detection and treatment of cholangiocarcinoma. Liver Transpl 2000;6(6 Suppl 2):S30–S34.CrossRefPubMedGoogle Scholar
  4. Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51Suppl 6:VI1–9.PubMedCrossRefGoogle Scholar
  5. Lau WY, Leow CK, Li AK. Hepatocellular carcinoma. Br J Hosp Med 1997;57:101–104.PubMedGoogle Scholar
  6. Nagorney DM, Gigot JF. Primary epithelial hepatic malignancies: etiology, epidemiology, and outcome after subtotal and total hepatic resection. Surg Oncol Clin North Am 1996;5:283–300.Google Scholar
  7. Nair S, Shiv Kumar K, Thuluvath PJ, et al. Mortality from hepatocellular and biliary cancers: changing epiderniological trends. Am J Gastroenterol 2002;97:167–171, Erratum in: Am J Gastroenterol 2002;97:2484, Am J Gastroenterol 2002;97:1280.CrossRefPubMedGoogle Scholar
  8. Sakon M, Nagano H, Nakamori S, et al. Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg 2002;137:94–99.CrossRefPubMedGoogle Scholar
  9. Slakey DP. Radiofrequency ablation of recurrent cholangiocarcinoma. Am Surg 2002;68:395–397.PubMedGoogle Scholar
  10. Tsao JI, DeSanctis J, Rossi RL, et al. Hepatic malignancies. Surg Clin North Am 2000;80:603–632.CrossRefPubMedGoogle Scholar
  11. Varnholt H, Weimann A, Wittekind C, et al. Intrahepatic cholangiocarcinoma. J Am Coll Surg 2002;194:550–551.CrossRefPubMedGoogle Scholar

Metastatic Neoplasms of the Liver

  1. Cady B, Stone MD, McDermott WV Jr, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992;127:561–569.PubMedGoogle Scholar
  2. Langer B, Gallinger S. The management of metastatic carcinoma in the liver. Adv Surg 1995;28:113–132.PubMedGoogle Scholar
  3. Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988;103:278–288.Google Scholar

Hepatic Resection

  1. Bismuth H, Dennison AR. Segmental liver resection. Adv Surg 1993;26:189–208.PubMedGoogle Scholar
  2. Emre S, Schwartz ME, Katz E, et al. Liver resection under total vascular isolation. Variations on a theme. Ann Surg 1993;217:15–19.PubMedGoogle Scholar
  3. Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999;229:322–330.CrossRefPubMedGoogle Scholar
  4. Launois B, Jamieson GG. The importance of Glisson’s capsule and its sheaths in the intrahepatic approach to resection of the liver. Surg Gynecol Obstet 1992;174:7–10.PubMedGoogle Scholar
  5. Taniguchi H, Takahashi T, Shioaki Y, et al. Vascular inflow exclusion and hepatic resection. Br J Surg 1992;79:672–675.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 2004

Personalised recommendations